Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Routledge

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Cureus|March 6, 2023
Re-Tear Rates Following Rotator Cuff Repair SurgeryJamie C Routledge, Ahmed Y Saber, Neil Pennington, et al.
European Journal of Pharmacology|August 3, 1993
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis studyC Routledge, J Gurling, I K Wright, et al.
Leukemia Research|January 1, 1987
Inhibition of normal human granulopoiesis in vitro by amiloride: evidence for the involvement of facilitated sodium influx in the induction of differentiationA J Steed, R Pylypczuk, R C Routledge, et al.
European Journal of Pharmacology|April 4, 1995
Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190C Routledge, J Gurling, M A Ashworth-Preece, et al.
Clinical Science (London, England : 1979)|August 1, 2002
Cardiac vagal response to water ingestion in normal human subjectsHelen C Routledge, Saqib Chowdhary, John H Coote, et al.
British Journal of Pharmacology|September 1, 1985
The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivoM P Brazell, C A Marsden, A P Nisbet, et al.
Postgraduate Medical Journal|September 1, 1989
Bacterial calcification in infective endocarditisD N Poller, A Curry, L A Ganguli, et al.
The Journal of Laryngology and Otology|June 29, 2001
Relapsing polychondritis associated with monoclonal gammopathy in a patient with myelodysplastic syndromeS S Banerjee, D P Morris, M P Rothera, et al.
Neuropharmacology|June 1, 1997
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptorsL Thorn, T E Ashmeade, V J Storey, et al.
Cureus|October 18, 2023
Management of Distal Femur Fractures: Replacement Versus Surgical Fixation Versus Conservative ManagementJamie C Routledge, Oladimeji Bashir, Mohamed Elbeshbeshy, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cureus|March 6, 2023
Re-Tear Rates Following Rotator Cuff Repair SurgeryJamie C Routledge, Ahmed Y Saber, Neil Pennington, et al.
European Journal of Pharmacology|August 3, 1993
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis studyC Routledge, J Gurling, I K Wright, et al.
Leukemia Research|January 1, 1987
Inhibition of normal human granulopoiesis in vitro by amiloride: evidence for the involvement of facilitated sodium influx in the induction of differentiationA J Steed, R Pylypczuk, R C Routledge, et al.
European Journal of Pharmacology|April 4, 1995
Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190C Routledge, J Gurling, M A Ashworth-Preece, et al.
Clinical Science (London, England : 1979)|August 1, 2002
Cardiac vagal response to water ingestion in normal human subjectsHelen C Routledge, Saqib Chowdhary, John H Coote, et al.
British Journal of Pharmacology|September 1, 1985
The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivoM P Brazell, C A Marsden, A P Nisbet, et al.
Postgraduate Medical Journal|September 1, 1989
Bacterial calcification in infective endocarditisD N Poller, A Curry, L A Ganguli, et al.
The Journal of Laryngology and Otology|June 29, 2001
Relapsing polychondritis associated with monoclonal gammopathy in a patient with myelodysplastic syndromeS S Banerjee, D P Morris, M P Rothera, et al.
Neuropharmacology|June 1, 1997
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptorsL Thorn, T E Ashmeade, V J Storey, et al.
Cureus|October 18, 2023
Management of Distal Femur Fractures: Replacement Versus Surgical Fixation Versus Conservative ManagementJamie C Routledge, Oladimeji Bashir, Mohamed Elbeshbeshy, et al.
Pageof 6